Lv1
60 积分 2025-12-09 加入
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis
1个月前
已完结
Astragaloside I from Astragalus Attenuates Diabetic Kidney Disease by Regulating HDAC3/Klotho/TGF-β1 Loop
2个月前
已完结
Astragaloside IV Alleviates Cisplatin Chemotherapy‐Induced Nephrotoxicity via Modulation of Nrf2/HO‐1/NF‐κB Pathway and Reversal of EMT Process
8个月前
已完结
Astragaloside IV synergizes with ferulic acid to suppress hepatic stellate cells activationin vitro
8个月前
已完结
Astragaloside IV Alleviates Atorvastatin-Induced Hepatotoxicity via AMPK/SIRT1 Pathway
8个月前
已完结
Research review on the pharmacological effects of astragalosideIV
8个月前
已完结
Astragaloside I from Astragalus Attenuates Diabetic Kidney Disease by Regulating HDAC3/Klotho/TGF-β1 Loop
8个月前
已完结
Astragaloside IV ameliorates renal fibrosis via the inhibition of mitogen-activated protein kinases and antiapoptosis in vivo and in vitro
8个月前
已完结
Inhibitory Effects of Astragaloside IV on Bleomycin-Induced Pulmonary Fibrosis in Rats Via Attenuation of Oxidative Stress and Inflammation
8个月前
已完结
Astragaloside IV restrains pulmonary fibrosis progression via the circ_0008898/miR‐211‐5p/HMGB1 axis
8个月前
已完结
皖公网安备34019202002308
